Holista CollTech Limited - HCT share price
About Holista CollTech Limited
Holista Colltech Ltd is a research-driven biotech company. The Company is focused on researching, developing, manufacturing, and marketing health-style products to address the unmet and growing needs of natural medicine. The Company’s segments include Supplements, Ovine Collagen, Infection Control Solutions/Agriculture, Food Ingredients, and Corporate. The Supplements segment is involved in the manufacture and wholesale distribution of dietary supplements. The Ovine collagen segment is involved in the manufacture and distribution of cosmetic-grade collagen. The Food ingredients segment is involved in the manufacture and wholesale distribution of healthy food ingredients. The Infection control Solutions segment is involved in infection control solutions. The Company’s products include LOGIC Sweet and Low GI. The Company's subsidiaries include Holista Biotech Sdn Bhd, Alterni (M) Sdn Bhd, Revonutrix Sdn Bhd, Medi Botanics Sdn Bhd, Total Health Concept Sdn Bhd, and others.
Company Profile
Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.
Price Summary
Try Veye Free for 7 Days
Expert ASX stock picks, in-depth research & buy/sell signals — free for a full week.
No credit card required
Price Chart (HCT)
TOP ASX STOCKS Worth Watching
- ✓ Instant Access
- ✓ No Credit Card Required
- ✓ Free to join · No spam
Free to join · No spam · Unsubscribe anytime
By providing your details, you agree to Veye's Terms & Conditions, Privacy Policy, and Financial Services Guide and to receive marketing offers. Before you access our services, please read the Financial Services Guide available here.
Discover the Top ASX Stocks to Invest in 2026!
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Reports from Veye
Latest Article